Hbk Investments L P Novo Nordisk A S Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$46.76 - $51.24 $4.83 Million - $5.29 Million	-103,193 Reduced 42.94%	137,107 $6.46 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $7.23 Million - $8.23 Million	163,291 Added 212.04%	240,300 $11.1 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $3.39 Million - $4.07 Million	70,009 Added 1000.13%	77,009 $3.79 Million
Q4 2017 Feb 14, 2018	BUY	$47.53 - $53.73 $332,710 - $376,110	7,000	7,000 $376,000

1,957

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $192B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.